OR Royalties Inc. $OR is Louisbourg Investments Inc.’s 6th Largest Position

Louisbourg Investments Inc. cut its holdings in shares of OR Royalties Inc. (NYSE:OR) by 16.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 292,871 shares of the basic materials company’s stock after selling 55,960 shares during the period. OR Royalties comprises about 2.4% of Louisbourg Investments Inc.’s investment portfolio, making the stock its 6th biggest holding. Louisbourg Investments Inc.’s holdings in OR Royalties were worth $11,735,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Plato Investment Management Ltd acquired a new position in shares of OR Royalties in the first quarter worth about $56,000. Hsbc Holdings PLC acquired a new position in shares of OR Royalties in the 1st quarter valued at approximately $208,000. Twin Tree Management LP purchased a new position in shares of OR Royalties during the 2nd quarter valued at approximately $245,000. Trexquant Investment LP acquired a new stake in shares of OR Royalties during the first quarter worth approximately $248,000. Finally, Brevan Howard Capital Management LP acquired a new stake in shares of OR Royalties during the second quarter worth approximately $288,000. 68.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Canaccord Genuity Group raised shares of OR Royalties from a “hold” rating to a “strong-buy” rating in a report on Wednesday, October 22nd. Weiss Ratings reissued a “buy (b)” rating on shares of OR Royalties in a research report on Monday. Wall Street Zen upgraded shares of OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Jefferies Financial Group reaffirmed a “hold” rating and set a $38.00 price target on shares of OR Royalties in a research report on Sunday, December 7th. Finally, Zacks Research upgraded OR Royalties from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 6th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $35.75.

OR Royalties Stock Performance

Shares of OR opened at $36.93 on Friday. The firm has a fifty day moving average of $34.08 and a 200-day moving average of $31.92. The company has a market cap of $6.94 billion, a price-to-earnings ratio of 46.75 and a beta of 0.81. OR Royalties Inc. has a 1 year low of $17.55 and a 1 year high of $42.25.

OR Royalties (NYSE:OR) last released its quarterly earnings data on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. The business had revenue of $71.63 million for the quarter, compared to analysts’ expectations of $53.85 million. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. Analysts predict that OR Royalties Inc. will post 0.62 EPS for the current year.

OR Royalties Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.055 per share. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, December 31st. OR Royalties’s payout ratio is 27.85%.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.